Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TEVA PHARMACEUTICAL INDUSTRIES, LTD.”

302 pharma patents match "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 302
Index total 30,257
Page 5 / 13

Quick answer

This filtered view shows 302 pharmaceutical patents matching "TEVA PHARMACEUTICAL INDUSTRIES, LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

302 results for “TEVA PHARMACEUTICAL INDUSTRIES, LTD.” · 30,257 patents in full index Clear search

  1. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  2. US 8080672

    Crystal form of atorvastatin hemi-calcium and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  3. US 8071638

    Solid states of atorvastatin potassium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  4. US 8067473

    Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  5. US 8067423

    Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  6. US 8063211

    Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  7. US 8063250

    Crystal forms of O-desmethylvenlafaxine fumarate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  8. US 8048222

    Highly pure modafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  9. US 8039620

    Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  10. US 8022094

    Carvedilol phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted
  11. US 8022190

    Immuno-molecules containing viral proteins, compositions thereof and methods of using

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted
  12. US 7994178

    Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted
  13. US 7989473

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted
  14. US 7977457

    Fusion proteins, uses thereof and processes for producing same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted
  15. US 7973045

    Anhydrous form of dasatinib and process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted
  16. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  17. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  18. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  19. US 7960586

    Purification of armodafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted
  20. US 7923215

    Process for the measurement of the potency of glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted
  21. US 7915423

    Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted
  22. US 7915412

    Process for the synthesis of 9-hydroxy risperidone (paliperidone)

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted
  23. US 7884208

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  24. US 7884226

    Purification of rosuvatatin intermediate by thin film evaporation and chemical method

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted